We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amgen Brings Suit Against Yet Another Neulasta Biosimilar Maker: Mylan
Amgen Brings Suit Against Yet Another Neulasta Biosimilar Maker: Mylan
Amgen leveled new biosimilar patent infringement litigation against Mylan, after the generics manufacturer submitted an FDA application for its version of the company’s Neulasta (pegfilgrastim) therapy earlier this year.